Pfizer and its partner BioNTech strategy to lookfor emergencysituation permission for a 2nd COVID-19 booster shot for individuals 65 and older, Axios hasactually verified.
Driving the news: The relocation is an effort to fight subsiding resistance that happens anumberof months after a veryfirst booster shot, according to the Washington Post, which veryfirst reported the news.
- The submission to the Food and Drug Administration is anticipated to consistof information from Israel, which is one of a coupleof nations that have authorized a 2nd round of booster shots for anybody over 60, according to the Post.
State of play: Pfizer CEO Albert Bourla said on Sunday that a 4th dosage of the COVID-19 vaccine “is essential” to keep workable levels of hospitalizations and moderate infections.
- Meanwhile, NIAID director Anthony Fauci stated last month that the possibility of another round of boosters was being “very thoroughly kepttrackof.”
What to watch: The choice from the FDA on whether to license a 2nd booster dosage for older Americans might come rapidly, specifically if the information offered does not need evaluate by a panel of vaccine specialists, per the Post.
Go muchdeeper: Pfizer CEO states 4th shot of COVID vaccine “necessary”
Comments
Post a Comment